Literature DB >> 17108071

CTX-M beta-lactamase-producing Escherichia coli in French hospitals: prevalence, molecular epidemiology, and risk factors.

Jean-Philippe Lavigne1, Hélène Marchandin, Julien Delmas, Jérôme Moreau, Nicole Bouziges, Evelyne Lecaillon, Laurent Cavalie, Hélène Jean-Pierre, Richard Bonnet, Albert Sotto.   

Abstract

In 2004, 65 CTX-M-producing Escherichia coli isolates were collected from infected patients in four French hospitals. The blaCTX-M-15 genes were predominant. Pulsed-field gel electrophoresis highlighted a clonal propagation of CTX-M-15-producing strains belonging to phylogenetic group B2, notably in the community. The main risk factors for acquiring these isolates were urinary tract infections or the presence of a urinary catheter in diabetic or renal failure patients.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17108071      PMCID： PMC1829058          DOI： 10.1128/JCM.01917-06

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  46 in total

Review 1.  Growing group of extended-spectrum beta-lactamases: the CTX-M enzymes.

Authors:  R Bonnet
Journal:  Antimicrob Agents Chemother       Date:  2004-01       Impact factor: 5.191

2.  Epidemiology and clinical features of infections caused by extended-spectrum beta-lactamase-producing Escherichia coli in nonhospitalized patients.

Authors:  Jesús Rodríguez-Baño; Maria Dolores Navarro; Luisa Romero; Luis Martínez-Martínez; Miguel A Muniain; Evelio J Perea; Ramón Pérez-Cano; Alvaro Pascual
Journal:  J Clin Microbiol       Date:  2004-03       Impact factor: 5.948

3.  qnrA in CTX-M-producing Escherichia coli isolates from France.

Authors:  Jean-Philippe Lavigne; Hélène Marchandin; Julien Delmas; Nicole Bouziges; Evelyne Lecaillon; Laurent Cavalie; Hélène Jean-Pierre; Richard Bonnet; Albert Sotto
Journal:  Antimicrob Agents Chemother       Date:  2006-09-18       Impact factor: 5.191

4.  Molecular epidemiology of Enterobacteriaceae isolates producing extended-spectrum beta-lactamases in a French hospital.

Authors:  Jean-Philippe Lavigne; Nicole Bouziges; Catherine Chanal; Aba Mahamat; Sylvie Michaux-Charachon; Albert Sotto
Journal:  J Clin Microbiol       Date:  2004-08       Impact factor: 5.948

5.  Extended-spectrum beta-lactamase-producing Enterobacteriaceae in community and private health care centers.

Authors:  Corinne Arpin; Véronique Dubois; Laure Coulange; Catherine André; Isabelle Fischer; Patrick Noury; Frédéric Grobost; Jean-Philippe Brochet; Jacqueline Jullin; Brigitte Dutilh; Gilberte Larribet; Isabelle Lagrange; Claudine Quentin
Journal:  Antimicrob Agents Chemother       Date:  2003-11       Impact factor: 5.191

6.  Frequency and diversity of Class A extended-spectrum beta-lactamases in hospitals of the Auvergne, France: a 2 year prospective study.

Authors:  C De Champs; C Chanal; D Sirot; R Baraduc; J P Romaszko; R Bonnet; A Plaidy; M Boyer; E Carroy; M C Gbadamassi; S Laluque; O Oules; M C Poupart; M Villemain; J Sirot
Journal:  J Antimicrob Chemother       Date:  2004-07-28       Impact factor: 5.790

7.  Dissemination of CTX-M type beta-lactamases in Enterobacteriaceae isolates in the People's Republic of China.

Authors:  C J Munday; J Xiong; C Li; D Shen; P M Hawkey
Journal:  Int J Antimicrob Agents       Date:  2004-02       Impact factor: 5.283

8.  Extended-spectrum beta-lactamase (ESBL) CTX-M-15-producing Escherichia coli and Klebsiella pneumoniae in Sofia, Bulgaria.

Authors:  R Markovska; I Schneider; E Keuleyan; A Bauernfeind
Journal:  Clin Microbiol Infect       Date:  2004-08       Impact factor: 8.067

9.  Dissemination of CTX-M-type beta-lactamases among clinical isolates of Enterobacteriaceae in Paris, France.

Authors:  C Eckert; V Gautier; M Saladin-Allard; N Hidri; C Verdet; Z Ould-Hocine; G Barnaud; F Delisle; A Rossier; T Lambert; A Philippon; G Arlet
Journal:  Antimicrob Agents Chemother       Date:  2004-04       Impact factor: 5.191

10.  CTX-M-type beta-lactamases affect community Escherichia coli treatment, Greece.

Authors:  Spyros Pournaras; Alexandros Ikonomidis; Danai Sofianou; Athanassios Tsakris; Antonios N Maniatis
Journal:  Emerg Infect Dis       Date:  2004-06       Impact factor: 6.883
View more
  15 in total

1.  High prevalence of plasmid-mediated quinolone resistance genes qnr and aac(6')-Ib-cr in clinical isolates of Enterobacteriaceae from nine teaching hospitals in China.

Authors:  Hong Yang; Hongbin Chen; Qiwen Yang; Minjun Chen; Hui Wang
Journal:  Antimicrob Agents Chemother       Date:  2008-09-22       Impact factor: 5.191

2.  Modulation of Membrane Influx and Efflux in Escherichia coli Sequence Type 131 Has an Impact on Bacterial Motility, Biofilm Formation, and Virulence in a Caenorhabditis elegans Model.

Authors:  Alix Pantel; Catherine Dunyach-Remy; Christelle Ngba Essebe; Jennifer Mesureur; Albert Sotto; Jean-Marie Pagès; Marie-Hélène Nicolas-Chanoine; Jean-Philippe Lavigne
Journal:  Antimicrob Agents Chemother       Date:  2016-04-22       Impact factor: 5.191

3.  Clinical impact and risk factors for colonization with extended-spectrum β-lactamase-producing bacteria in the intensive care unit.

Authors:  Keyvan Razazi; Lennie P G Derde; Marine Verachten; Patrick Legrand; Philippe Lesprit; Christian Brun-Buisson
Journal:  Intensive Care Med       Date:  2012-08-15       Impact factor: 17.440

4.  Risk factors for infection or colonization with CTX-M extended-spectrum-β-lactamase-positive Escherichia coli.

Authors:  Jennifer H Han; Kei Kasahara; Paul H Edelstein; Warren B Bilker; Ebbing Lautenbach
Journal:  Antimicrob Agents Chemother       Date:  2012-08-13       Impact factor: 5.191

5.  Risk factors and outcomes of Escherichia coli bacteremia caused by strains that produce CTX-M or non-CTX-M extended-spectrum-beta-lactamases.

Authors:  U-I Wu; J-L Wang; W-C Chen; S-C Chang; Y-C Chen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-09-17       Impact factor: 3.267

Review 6.  The continuing challenge of ESBLs.

Authors:  Federico Perez; Andrea Endimiani; Kristine M Hujer; Robert A Bonomo
Journal:  Curr Opin Pharmacol       Date:  2007-09-17       Impact factor: 5.547

7.  Molecular epidemiology of Escherichia coli producing extended-spectrum beta-lactamases isolated in Rome, Italy.

Authors:  Alessandra Carattoli; Aurora García-Fernández; Paola Varesi; Daniela Fortini; Serena Gerardi; Adriano Penni; Carlo Mancini; Alessandra Giordano
Journal:  J Clin Microbiol       Date:  2007-10-24       Impact factor: 5.948

8.  Nationwide study of the prevalence, characteristics, and molecular epidemiology of extended-spectrum-beta-lactamase-producing Enterobacteriaceae in France.

Authors:  Muriel Galas; Jean-Winoc Decousser; Nelly Breton; Thierry Godard; Pierre Yves Allouch; Patrick Pina
Journal:  Antimicrob Agents Chemother       Date:  2007-11-19       Impact factor: 5.191

9.  Trends of methicillin-resistant Staphylococcus aureus (MRSA) and Enterobacteriaceae-producing extended-spectrum beta-lactamase (ESBLE) in eastern France: a three-year multi-centre incidence study.

Authors:  X Bertrand; L Mouchot; M Jebabli; O Bajolet; S Aho; M-F Blech; C Eloy; N Floret; S Gayet; D Talon; H Tronel
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-05-17       Impact factor: 3.267

10.  Increase in hospital-acquired bloodstream infections caused by extended spectrum beta-lactamase-producing Escherichia coli in a large French teaching hospital.

Authors:  L Drieux; F Brossier; O Duquesnoy; A Aubry; J Robert; W Sougakoff; M Lecso-Bornet; V Jarlier
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-11-12       Impact factor: 3.267
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.